Similar articles

• Randomized comparison of combination chemotherapy with etoposide, bleomycin, and either high-dose or standard-dose cisplatin in children and adolescents with high-risk malignant germ cell tumors: a pediatric intergroup study--Pediatric Oncology Group 9049 and Children's Cancer Group 8882.

  Cushing B, Giller R, Cullen JW, Marina NM, Lauer SJ, Olson TA, Rogers PC, Colombani P, Rescorla F, Billmire DF, Vinocur CD, Hawkins EP, Davis MM, Perlman EJ, London WB, Castleberry RP; Pediatric Oncology Group 9049; Children's Cancer Group 8882. Cushing B, et al. J Clin Oncol. 2004 Jul 1;22(13):2691-700. doi: 10.1200/JCO.2004.08.015. J Clin Oncol. 2004. PMID: 15226336 Clinical Trial.
• Nondysgerminomatous ovarian tumors: clinical characteristics, treatment, and outcome. A case-controlled study.

  Ghaemmaghami F, Hasanzadeh M, Karimi Zarchi M, Fallahi A. Ghaemmaghami F, et al. Int J Surg. 2008 Oct;6(5):382-6. doi: 10.1016/j.ijsu.2008.07.002. Epub 2008 Jul 16. Int J Surg. 2008. PMID: 18715834
• Long-term followup results of 1 cycle of adjuvant bleomycin, etoposide and cisplatin chemotherapy for high risk clinical stage I nonseminomatous germ cell tumors of the testis.

  Westermann DH, Schefer H, Thalmann GN, Karamitopoulou-Diamantis E, Fey MF, Studer UE. Westermann DH, et al. J Urol. 2008 Jan;179(1):163-6. doi: 10.1016/j.juro.2007.08.172. Epub 2007 Nov 14. J Urol. 2008. PMID: 18001800 Clinical Trial.
• High dose chemotherapy in germ cell tumors.

  Rosti G, De Giorgi U. Rosti G, et al. Tunis Med. 2005 Dec;83 Suppl 12:85-6. Tunis Med. 2005. PMID: 16430076 Review. No abstract available.
• [Treatment of malignant ovarian germ cell tumor and sex cord tumors].

  Sugiyama T, Ohta S, Tomonari R, Kamura T. Sugiyama T, et al. Gan To Kagaku Ryoho. 2002 Aug;29(8):1358-62. Gan To Kagaku Ryoho. 2002. PMID: 12214461 Review. Japanese.